PRF Technologies (PRFX) Non-Current Assets (2019 - 2025)
PRF Technologies (PRFX) recorded quarterly Non-Current Assets of $7.6 million in Q4 2025, up 5.43% on a QoQ basis from $7.3 million in Q2 2025, and up 69418.18% year-over-year from N/an in Q4 2024.
PRF Technologies (PRFX) Non-Current Assets (2019 - 2025) Analysis & Trends
PRF Technologies has disclosed Non-Current Assets across 7 years of filings, most recently posting $7.6 million for Q4 2025.
- Quarterly Non-Current Assets rose 69418.18% year-over-year to $7.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 million (up 70545.45% YoY) and the FY2025 annual result came in at $7.6 million, up 69418.18% from the prior year.
- Non-Current Assets improved to $7.6 million in Q4 2025, from $7.3 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $7.6 million in Q4 2025 and troughed at $11000.0 in Q4 2024.
- A 5-year average of $924352.9 and a median of $44000.0 in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2021 — Non-Current Assets sank 91.24% — and 2025, when it surged 69418.18%.
- Tracing PRFX's Non-Current Assets over 5 years: stood at $53000.0 in 2021, then slipped by 16.98% to $44000.0 in 2022, then sank by 59.09% to $18000.0 in 2023, then plunged by 38.89% to $11000.0 in 2024, then jumped by 69418.18% to $7.6 million in 2025.
- Business Quant data shows PRFX's Non-Current Assets at $7.6 million in Q4 2025, $7.3 million in Q2 2025, and $11000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | 7.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.65 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Dec 31, 2024 | 11,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 44,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Mar 31, 2022 | 51,000.00 |
| Dec 31, 2021 | 53,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Dec 31, 2020 | 10,000.00 |
| Jun 30, 2020 | 274,000.00 |
| Dec 31, 2019 | 192,000.00 |